Year: 2021
Type: article
Abstract: The publication of the Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines ( 1) is an important development for patients with HHT and their clinical caretakers.The guidelines include 2 new screening recommendations: Screening for brain vascular malformations (VMs) is recommended in "children with HHT or [those] at risk for HHT at the time of presentation/diagnosis," and screening for liver VMs should "be offered to adults with definite or suspected HHT."As a coauthor of these guidelines, I have already raised concerns about and objected to these recommendations.As a condition of my coauthorship, I have pledged to publish a dissenting opinion together with the guidelines.Two seminal publications from the World Health Organization address the principles of screening (2, 3).Many preconditions for screening described in these publications are not fulfilled by the screening recommendations for brain or liver
Source: Annals of Internal Medicine
DOI: 10.7326/l21-0245
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Award: G837815669
OpenAlex ID: W3183320745